Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

Autor: Matthias Egger, Fatoumata Dicko, Dorita Avila, Manuel Koller, Kara Wools-Kaloustian, Kulkanya Chokephaibulkit, Huu Khanh Truong, Rohan Hazra, Cleophas Chimbetete, Mary-Ann Davies, Samual Ayaya, Kunjal Patel, Benjamin C. Chi, Valériane Leroy

Publikováno v: Koller, Manuel; Patel, Kunjal; Chi, Benjamin H; Wools-Kaloustian, Kara; Dicko, Fatoumata; Chokephaibulkit, Kulkanya; Chimbetete, Cleophas; Avila, Dorita; Hazra, Rohan; Ayaya, Samual; Leroy, Valeriane; Truong, Huu Khanh; Egger, Matthias; Davies, Mary-Ann (2015). Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. Journal of acquired immune deficiency syndromes JAIDS, 68(1), pp. 62-72. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000380
ResearcherID

BACKGROUND The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) is an important prognostic factor in children starting therapy and an important indicator of program performance. We describe trends and determi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df4cc0b72c18bd702983a90f571afd11
https://doi.org/10.1097/qai.0000000000000380